A detailed history of Stonebridge Financial Group, LLC transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Stonebridge Financial Group, LLC holds 25 shares of XTNT stock, worth $13. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Holding current value
$13
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$0.35 - $0.66 $8 - $16
25 New
25 $11,000

Others Institutions Holding XTNT

About Xtant Medical Holdings, Inc.


  • Ticker XTNT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 108,226,000
  • Market Cap $56.3M
  • Description
  • Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...
More about XTNT
Track This Portfolio

Track Stonebridge Financial Group, LLC Portfolio

Follow Stonebridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Financial Group, LLC with notifications on news.